Gain Clarity in Complexity: Transforming Neurodegeneration Research with Biomarker Precision
Date: Sep 17, 2025
Launch event for the Olink® Target 48 Neurodegeneration Panel. This session explores how Olink® Target 48 Neurodegeneration empowers scientists to gain translational insights into complex disease biology through precise biomarker quantification and robust cross-study comparisons.
Product insightsA Complete Solution for Identifying Protein Signatures: From Sample to Actionable Results
Explore how the Olink® Signature Q100 benchtop system and NPX Signature software are part of a complete solution for generating meaningful protein signatures, from study design to data interpretation.
03 Apr 2025
- Application focus
Immune-competent vascularized human cerebral organoids to study brain development and disease: a multiomics approach
The Network Biology Collaborative Centre at Mount Sinai Hospital, an Olink Certified Service Provider, present their application of Olink’s Proximity Extension Assay technology to profile an organoid-based model that provides novel regulatory and mechanistic insights into human brain development.
13 Feb 2025
- Application focus
The Proteomics Frontier Webinar Series: Transforming Neurology and Driving Precision Medicine
Dive into the transformative power of Olink's proteomics platform and its revolutionary impact on neurological research and precision medicine. Learn how large-scale protein studies are unlocking the secrets of neurological disorders and revolutionizing medicine.
27 Mar 2025